Multimorbidity Patterns of Asthma Exacerbation in an Older Cohort: Prognostic Implications
The Journal of Allergy and Clinical Immunology: In Practice · 2025
DOI: 10.1016/j.jaip.2025.03.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025. Verfasst von Ying-Ying Ge und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Asthma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality, Peking University, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Asthma frequently coexists with other diseases associated with poor asthma control and low quality of life. Asthma exacerbation refers to severe episodes of disease worsening. Few studies have focused on identifying multimorbidity patterns in asthma and assessing their effects on asthma exacerbation. OBJECTIVE: To identify distinct multimorbidity patterns associated with asthma exacerbation in an older cohort and evaluate their impact on prognosis. METHODS: We performed a mini batch K-means clustering analysis of the comorbidities of 849 patients with asthma in this retrospective cohort study. Logistic regression analysis was performed to quantify independent associations between the identified phenotypes and outcomes. RESULTS: We identified four multimorbidity patterns in patients with asthma. Clusters 1 (n = 232; 27.33%), 2 (n = 122; 14.37%), 3 (n = 149; 17.55%), and 4 (n = 346; 40.75%) were characterized by predominantly allergic, predominantly respiratory, predominantly cardiometabolic, and fewer comorbidities, respectively. Cluster 2 was at significantly increased risk of intensive care unit admission (odds ratio [OR] = 2.30), noninvasive ventilation (OR = 2.68), mechanical ventilation (OR = 1.93) and 1-year emergency department revisits for asthma (OR = 3.10). Cluster 3 had the highest risk of 1-year readmission for comorbidities (OR = 2.53) and 1-year emergency department revisit for comorbidities (OR = 1.84). CONCLUSIONS: We identified four multimorbidity patterns associated with clinical characteristics and adverse outcomes in patients at risk for asthma exacerbation. Comorbidities can be recognized as treatable traits that can minimize the risk of future exacerbations and the adverse effects of asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
- Information Management and Big Data Center, Peking University Third Hospital, Beijing, China.
- Information Management and Big Data Center, Peking University Third Hospital, Beijing, China. Electronic address: ji_hong@126.com.
- Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China. Electronic address: doudou_1977@163.com.
Förderung
- Natural Science Foundation of Beijing Municipality
- Peking University
- National Natural Science Foundation of China
Zitieren
APA
Ge, Y. Y., Zuo, R., Xi, H. X., Zhang, C., Li, W., Chen, Y. H., Sun, Y. C., Ji, H., & Chang, C. (2025). Multimorbidity Patterns of Asthma Exacerbation in an Older Cohort: Prognostic Implications. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2025.03.047
Vancouver
Ge YY, Zuo R, Xi HX, Zhang C, Li W, Chen YH, et al. Multimorbidity Patterns of Asthma Exacerbation in an Older Cohort: Prognostic Implications. The Journal of Allergy and Clinical Immunology: In Practice. 2025. doi:10.1016/j.jaip.2025.03.047
BibTeX
@article{Ge2025,
author = {Ge, Ying-Ying and Zuo, Rui and Xi, Han-Xu and Zhang, Chen and Li, Wei and Chen, Ya-Hong and Sun, Yong-Chang and Ji, Hong and Chang, Chun},
title = {Multimorbidity Patterns of Asthma Exacerbation in an Older Cohort: Prognostic Implications},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2025},
doi = {10.1016/j.jaip.2025.03.047}
}
EUVIMED